Archangel Ventures kicks off rare 'community round' for medical AI startup Heidi
Eligible users of Heidi’s AI-powered “medical scribe” will be able to buy into the company’s blockbuster USD65 million Series B, which closed earlier this month.
Medical AI startup Heidi is allocating a slice of its recent USD65 million ($100 million) Series B round to Melbourne VC firm Archangel Ventures in a seldom seen “community round” that will offer eligible users of its platform the opportunity to invest.
Heidi’s customers – which range from independent clinicians to government health organisations – will be able to make minimum investments of USD5,000, so long as they are based in Australia and qualify as sophisticated or professional investors.
Early-stage investor Archangel, which has participated in each of Heidi’s investment rounds, is set to manage the two-week process, with expressions of interest closing on 7 November.
“It makes a whole lot of sense to let your supporters participate in the growth of the business,” Archangel’s managing partner Ben Armstrong told Capital Brief.
